UC Davis researchers develop computer model for testing heart-disease drugs

Computer-based simulations solve decades-old mystery of failed anti-arrhythmia therapy

2011-09-01

(Press-News.org) (SACRAMENTO, Calif.) — UC Davis researchers have developed an accurate computer model to test the effects of medications for arrhythmia, or abnormal heart rhythm, before they are used in patients.

The new tool -- described in the Aug. 31 issue of the journal Science Translational Medicine -- will help scientists screen anti-arrhythmia medications early in the drug-development pipeline and eventually guide physicians in prescribing those interventions to patients who could benefit the most.

"Drug development for arrhythmia has failed because it is difficult to anticipate how drugs will alter the heart's intricate electrical behavior prior to clinical trials," said Clancy, an associate professor of pharmacology at UC Davis and senior author of the study. "We developed a novel approach to solve this problem -- a computational framework for making early predictions about the effects of medications on cardiac rhythms."

In the 1980s, the Cardiac Arrhythmia Suppression Trial (CAST) study came to an abrupt halt when scientists discovered that the arrhythmia medication flecainide, used to treat abnormally fast heart rhythms, more than tripled the risk of sudden cardiac death compared to placebo in patients with irregular heartbeats.

"No one ever knew exactly why this happened, and we used our model to find out," said Clancy. "CAST gave us the clinical starting point for our study."

To further prove the model's utility, Clancy and her team also used it to test lidocaine, an anti-arrhythmia medication with a strong safety profile and sufficient clinical outcomes data.

In conducting the study, Clancy, a biophysicist who specializes in using high-performance computing to understand diseases arising from abnormal excitability, started with existing models that simulate the behavior of heart cells during both normal heart rhythms and arrhythmia. She then devised mathematical formulas to describe the interactions of flecainide and lidocaine with their specific cellular targets -- tiny pores in cell membranes called ion channels that are the foundation for cardiac electrical activity. She and her team used these models in a simulation study to predict the effects of these drugs on cardiac rhythms in a 3-D virtual heart.

The results can be seen as videos showing that in the setting of extra heartbeats, flecainide causes arrhythmia, the condition it was developed to treat. Arrhythmia was not observed with lidocaine, confirming this drug is a safer alternative.

"An additional benefit of this model is that we could see exactly how flecainide causes arrhythmia," Clancy said.

The test showed that flecainide detaches from ion channels very slowly, causing it to build up in cells. This drug action led to a loss of heartbeats in some portions of the heart but not others - a condition that can set the stage for arrhythmia.

According to the study's lead author, Jonathan D. Moreno, a major benefit of the computer-based drug-testing approach is that it allows researchers to follow many processes simultaneously.

"We can test treatments under a range of conditions, including various heart rates, drug concentrations and arrhythmia triggers," said Moreno, who was a graduate student in Clancy's lab when the study was conducted. "It could even be used to mix and match drugs to create multidrug regimens."

To confirm the results, Clancy and her team treated rabbit hearts with the two drugs and found that the simulation correctly predicted the heart rates and concentrations at which the adverse effects were seen with the computer model.

The researchers hope their model will provide the foundation for a virtual drug-testing system that could streamline the current approach, which is limited to just a few drugs and biological processes at a time. Clancy also hopes her research will lead to quicker discoveries of new arrhythmia therapeutics.

"Millions of people each year are affected by cardiac arrhythmias that don't respond well to medications or that must be controlled with implantable defibrillators that can reduce quality of life," said Clancy. "Our model will hopefully speed the discovery of new options."

### In addition to Clancy and Moreno (who is now at Cornell University), study co-authors were Pei-Chi Yang, Mao-Tsuen Jeng, Chaoyi Kang, Lianguo Wang and Crystal Ripplinger of UC Davis; Z. Iris Zhu and David Christini of Cornell University; John Bankston and Robert Kass of Columbia University; and Natalia Trayanova and Jason Bayer of Johns Hopkins University.

The research was supported by grants from the American Heart Association, the Alfred P. Sloan Foundation, the National Institutes of Health (NIH) National Heart, Lung and Blood Institute, the National Science Foundation, and the NIH/National Institute of General Medical Sciences Medical Scientist Training Program.

Journalists can request a copy of the study -- "A Computational Model to Predict the Effects of Class I Anti-Arrhythmic Drugs on Ventricular Rhythms" -- by contacting the American Association for the Advancement of Science at 1-202-326-6440 or scipak@aaas.org.

The UC Davis Department of Pharmacology has a dynamic group of faculty, researchers and students who are conducting investigations that ultimately lead to new drugs and drug targets for human diseases. Key research areas include cardiovascular and neural physiology/pharmacology, the genetic basis of disease, synaptic plasticity and development, autoimmune disorders and infectious diseases. These diverse areas of study are unified by common goals -- to understand the biological foundations of disease and to identify novel treatments or cures. For more information, visit http://www.ucdmc.ucdavis.edu/pharmacology/.

ELSE PRESS RELEASES FROM THIS DATE:

2011 New Jersey Super Lawyers Recognizes Hanan M. Isaacs

2011-09-01

The Kingston, New Jersey law firm of Hanan M. Isaacs is pleased to announce that managing partner Hanan Isaacs has been named by New Jersey Super Lawyers magazine as one of the top attorneys in New Jersey for 2011. Only five percent of the lawyers in the state are afforded this distinction by Super Lawyers. When asked about receiving this recognition for the second consecutive year, Attorney Isaacs said, "I am humbled to be recognized by Super Lawyers again this year. My focus is on effectively representing my New Jersey clients, so the recognition is gratifying." SUPER ...

Commonly used defibrillators raise risk of problems

2011-09-01

When it comes to defibrillators, simpler may be safer, even though more complex machines are used on a majority of patients. That's according to a new study from a team that included University of Colorado School of Medicine researcher Paul Varosy, MD. The group reviewed more than 100,000 records of cardiac patients. They found that there was more chance of surgical problems and death with devices that require electrical leads to be attached to two chambers of the heart compared to those that work on one chamber. Although there are potential theoretical benefits, the ...

Penn physicists develop new insight into how disordered solids deform

2011-09-01

PHILADELPHIA — In solid materials with regular atomic structures, figuring out weak points where the material will break under stress is relatively easy. But for disordered solids, like glass or sand, their disordered nature makes such predictions much more daunting tasks. Now, a collaboration combining a theoretical model with a first-of-its kind experiment has demonstrated a novel method for identifying "soft spots" in such materials. The findings from University of Pennsylvania and Syracuse University physicists may lead to better understanding of the principles that ...

Pennsylvania: More Concealed Carry Permits Than Average

2011-09-01

Few topics are as likely to provoke a heated response as concealed carry laws and their effect on crime. Proponents of the laws claim more guns mean less crime. In Pennsylvania, they certainly mean more guns. Concealed Carry Since the 1980s, the numbers of citizens licensed to carry a concealed gun has grown from less than a million to 6 million, The Daily Item reported recently. The story notes nearly 1 in 11 people in Synder County has a permit to carry a concealed weapon. Pennsylvania Above Average They point out that while 1 of 50 Americans has a license ...

Scripps Research scientists reveal how white blood cell promotes growth and spread of cancer

2011-09-01

LA JOLLA, CA – August 31, 2011 - Scientists at The Scripps Research Institute have shown that a particular white blood cell plays a direct role in the development and spread of cancerous tumors. Their work sheds new light on the development of the disease and points toward novel strategies for treating early-stage cancers. The study was published in September 2011 print issue of the American Journal of Pathology. Scripps Research Professor James Quigley, Staff Scientist Elena Deryugina, and colleagues had previously demonstrated that white blood cells known as neutrophils—bone ...

Trust in your neighbors could benefit your health, MU study shows

2011-09-01

COLUMBIA, Mo. – Here's an easy way to improve your health: trust your neighbors. A new study from the University of Missouri shows that increasing trust in neighbors is associated with better self-reported health. "I examined the idea of 'relative position,' or where one fits into the income distribution in their local community, as it applies to both trust of neighbors and self-rated health," said Eileen Bjornstrom, an assistant professor of sociology in the MU College of Arts and Science. "Because human beings engage in interpersonal comparisons in order to gauge ...

Members of Congress, Business Leaders Contemplate H-1B Visa Reform

2011-09-01

Increasing H-1B Visa Cap, Length of Stay May Improve Economy Innovation is one of the keys to a strong economy. The way to ensure more innovation in the U.S., some argue, is to improve immigration for highly-skilled professionals. This is the message that Congressman Darrell Issa (R-Calif.), Chairman of the House Oversight and Government Reform Committee, brought to a group of Silicon Valley executives during a hearing about how to improve the way the government processes visa applications. In particular, Congressman Issa called the H-1B visa system -- the nonimmigrant ...

Minnesota Motorcycle Deaths Up in 2011

2011-09-01

For motorcyclists in Minnesota, summer is the time to hit the road on a bike. This summer, however, riding is proving to be more dangerous than ever, as tragic accidents have risen alarmingly. Accidents involving motorcycles have killed at least 22 people so far this year in the state, up significantly from 2010. More Danger Ahead? Minnesota's Department of Public Safety is concerned that motorcycle deaths will only increase. "August and September are typically high-traffic and high-fatal months for riders," Bill Shaffer, the motorcycle program coordinator ...

Researchers share discoveries about aging-related changes in health and cognition

2011-09-01

Critical life course events and experiences — in both youth and middle adulthood — may contribute to health and cognition in later life, according to a new supplemental issue of the Journals of Gerontology Series B: Psychological Sciences and Social Sciences. Furthermore, the authors find that the processes of aging linked to cognition and those linked to health should be studied simultaneously, as part of the same set of processes. There also is an emerging consensus that a multidisciplinary theoretical approach is necessary to understand the nature of the processes ...

UF medicinal chemists modify sea bacteria byproduct for use as potential cancer drug

2011-09-01

University of Florida researchers have modified a toxic chemical produced by tiny marine microbes and successfully deployed it against laboratory models of colon cancer. Writing today in ACS Medicinal Chemistry Letters, UF medicinal chemists describe how they took a generally lethal byproduct of marine cyanobacteria and made it more specifically toxic — to cancer cells. When the scientists gave low doses of the compound to mice with a form of colon cancer, they found that it inhibited tumor growth without the overall poisonous effect of the natural product. Even at ...

LAST 30 PRESS RELEASES:

Ultrasound-directed microbubbles could boost immune response against tumours, new Concordia research suggests

In small preliminary study, fearful pet dogs exhibited significantly different microbiomes and metabolic molecules to non-fearful dogs, suggesting the gut-brain axis might be involved in fear behavior

Examination of Large Language Model "red-teaming" defines it as a non-malicious team-effort activity to seek LLMs' limits and identifies 35 different techniques used to test them

Most microplastics in French bottled and tap water are smaller than 20 µm - fine enough to pass into blood and organs, but below the EU-recommended detection limit

DARPA-ABC program supports Wyss Institute-led collaboration toward deeper understanding of anesthesia and safe drugs enabling anesthesia without the need for extensive monitoring

[Press-News.org] UC Davis researchers develop computer model for testing heart-disease drugs
Computer-based simulations solve decades-old mystery of failed anti-arrhythmia therapy